Go to Top
[maxbutton id="1"]

Dr. Richard S. Larson

richard-larsonExecutive Vice Chancellor
Vice Chancellor for Research, Health Sciences Center, UNM


AB – Chemistry, summa cum laude, University of North Carolina at Chapel Hill
PhD – Immunology, Harvard University
MD – Harvard Medical School

Business/Research Background

Dr. Larson is the Executive Vice Chancellor and Vice Chancellor for Research at the University of New Mexico Health Sciences Center. Dr. Larson oversees research endeavors at the Health Sciences Center as well as strategic planning and a number of operational, clinical and educational programs. Several of these programs support enhancement of diversity in our workforce. Dr. Larson received both his M.D. and Ph.D. from Harvard University and performed his residency training at Washington University at St. Louis and his fellowship training at Vanderbilt University.

Particular Knowledge and Skills

Dr. Larson’s accomplishments include over 100 published manuscripts and numerous patents. In addition, he edited the book Bioinformatics and Drug Discovery which was published in 2005, with a second edition published in 2012. His publication on the use of the novel non-DNA amplification platform for determining the presence of DNA mutations was chosen as manuscript of the year and appeared in the 2002 Yearbook of Pathology and Laboratory Medicine. In 2006, he and his collaborators at UNM and Sandia National Laboratories were awarded the Chief Scientist Award for their hand-held bio-agent sensor from the Defense Intelligence Agency. Recently, this hand-held detector was selected by R&D Magazine as one of the top products of 2010. As an established scholar and leader, Dr. Larson’s many accolades include the College of American Pathology Lansky Award for his leadership in and contribution to the practice of pathology and laboratory medicine, UNM Regents Lectureship for contributions to UNM, and the American Cancer Society Designated National Investigator for the Coaches against Cancer and Hoops for Lymphoma/Leukemia.

Dr. Larson is extensively involved in supporting and initiating several commercial ventures in New Mexico. He currently has commercial partnerships with Senior Scientific, Adaptive Methods, and Sandia National Laboratories and is a member of the Board of Directors for TriCore Reference Laboratory, New Mexico’s 10th largest company, where he has been involved in founding, operating and governance for over the last 16 years. He has also served on several non-profit and private company Boards of Directors. In 2001, he co-founded Cancer Services of New Mexico, a non-profit organization that serves, free of charge, over 2,000 New Mexicans suffering from cancer each year. He is President of the Cancer Services of New Mexico Foundation, and serves on the Board of Directors for Cancer Services of New Mexico.